25 Sep 2023
Tadaaki Taniguchi, Chief Medical Officer, shares his insights with @PharmaVoice on how to help teams adopt agile ways of working and thrive outside their comfort zones to meet the urgent needs of patients. #Changingtomorrow #ScienceFirstForPatients
1
700
4 Jan 2023
With growing recognition that partnerships are vital to accelerate our innovation, SVP, Primary Focus Lead Immuno-oncology, Peter Sandor shared his thoughts with @_CellandGene on how to advance a new era of cancer cell therapies. #ScienceFirstForPatients
3
892
3 Dec 2022
As the pharma industry rethinks clinical trial approaches, Marie Rosenfeld, SVP, Head of Clinical Science shares her thoughts with @ClinicalLeader1 about what Astellas has learned so far: bit.ly/3VxpFQL.
#ChangingTomorrow #ScienceFirstForPatients
1
4
10 Nov 2022
A shared culture of quality is a critical enabler of accelerating innovation. Our Head of Quality Assurance, David Fryrear, shares his thoughts with
@PharmExec.
#ChangingTomorrow #ScienceFirstForPatients
2
3
6 Sep 2022
What does it take to deliver next generation #cancer therapies and build a leadership position from the ground up?
Join us and @endpts as we discuss all things strategy, innovation, culture and partnerships. #ScienceFirstForPatients
2
3
23 Aug 2022
SVP, Primary Focus Lead Immuno-oncology, Peter Sandor speaks to @fwpharma, exploring how partnerships with a shared commitment to creating the right environment for innovation to flourish are some of the most powerful. Learn more bit.ly/3PIgJVg #ScienceFirstForPatients
1
2
3 Aug 2022
How can pharma evolve its approach to decentralized #clinicaltrials to give patients more choices? Our Head of Clinical Sciences Marie Rosenfeld shares her views with @medcitynews bit.ly/3SnvLCs. #ScienceFirstForPatients
1
3
17 May 2022
We’re working with the cancer community to find and accelerate the cures of tomorrow. Our Primary Focus Lead Immuno-oncology, Peter Sandor, shares how collaboration and new ways of working are driving progress for patients. #ChangingTomorrow #ScienceFirstForPatients
1
1
26 Apr 2022
Regulatory reform is ongoing globally and we have a unique opportunity to assess how we can deliver even greater value for patients. Our Head of Regulatory Affairs Stef Schutte shares his thoughts with @PharmExec. #ChangingTomorrow #ScienceFirstForPatients
3
4
15 Mar 2022
Our Chief Medical Officer Bernie Zeiher shares his five key lessons for innovating at the frontiers of science.
Read the article in @statnews to learn more.
#ChangingTomorrow
#ScienceFirstForPatients
1
1
14 Mar 2022
We are dedicating our collective strengths to find new ways to treat more cancers in more patients. Hear how we are transforming R&D in #immuno-oncology to redefine expectations of #cancer care and read on to learn more. #ChangingTomorrow #ScienceFirstForPatients
2
7 Feb 2022
Are we doing all we can to unlock the full potential of #RealWorldEvidence for patients? Our Medical Affairs leaders Charlotte Kremer and Judith Nelissen share their thoughts with @INVIVOnow. #ScienceFirstForPatients
2
14 Dec 2021
Weatherwax Biotechnologies and Vcreate win our two Astellas Future Innovator Prizes, granting a year’s access to @MBiolabs incubator and our R&D mentors! We are proud to support these #entrepreneurs to advance their #innovations. #ScienceFirstForPatients
2
1
2
9 Dec 2021
Instilling a culture of quality is key to realize the full potential of tomorrow’s innovation. Our Head of Quality Assurance David Fryrear shares his thoughts with @ThePharmaLetter. #ScienceFirstForPatients
3
3 Nov 2021
Thymmune Therapeutics and M13 Therapeutics win our two Astellas Future Innovator Prizes, granting a year’s access to @LabCentral incubator and our R&D mentors! We are proud to support these #entrepreneurs to advance their #innovations. #ScienceFirstForPatients
1
2
3
3 Sep 2021
SVP Joe Fleishaker shares how Astellas’ expert Clinical Pharmacology and Exploratory Development team helps to maximize the value of our therapies for patients. Read on to learn more. #ClinicalPharmacology #ScienceFirstForPatients #2021ACCP
3
28 Jul 2021
“Quality and excellence are the foundation of our work in healthcare.” CMO Bernie Zeiher shares insights with @PharmExec on the importance of embracing a ‘quality by design’ mindset to meet the needs of patients. #ChangingTomorrow #ScienceFirstForPatients
2
4
12 Jul 2021
Chief Medical Officer Bernie Zeiher shares his thoughts on the key lessons the pandemic taught biopharma and what they may hold for the future. #ChangingTomorrow #ScienceFirstForPatients
2
7 Apr 2021
Chief Business Officer Percival Barretto-Ko talks with @LEADERSMag about his new role driving innovation at Astellas, our inclusive culture and how we are focused on #ScienceFirstforPatients to create new medical solutions that bring value to patients with high unmet needs.
2
7
18 Mar 2021
“There’s nothing stopping us moving with the same sense of urgency and patient-partnership in the post COVID-19 world,” shared Bernie Zeiher, our CMO, with @INVIVOnow. #ScienceFirstForPatients
1
5